According to Glaukos's latest financial reports and stock price the company's current Operating Margin is -37.53%. At the end of 2022 the company had an Operating Margin of -34.80%.
Year | Operating Margin | Change |
---|---|---|
2022 | -34.80% | 107.66% |
2021 | -16.76% | -71.51% |
2020 | -58.82% | 178.57% |
2019 | -21.11% | 209.46% |
2018 | -6.82% | -1086637.51% |
2017 | 0.00% | -99.98% |
2016 | 3.99% | -107.47% |
2015 | -53.40% | 73.4% |
2014 | -30.80% | -54.64% |
2013 | -67.89% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
ICU Medical
ICUI | -5.01% | -86.65% | ๐บ๐ธ USA |
AtriCure ATRC | -13.98% | -62.75% | ๐บ๐ธ USA |
Integra LifeSciences IART | 13.73% | -136.58% | ๐บ๐ธ USA |
Hill-Rom HRC | 12.20% | -132.52% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.